SMS PHARMACEUTICALS
Back to Income Statement
|
SMS PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹783 Cr | ₹709 Cr | ₹522 Cr | ₹520 Cr | ₹563 Cr |
What is the latest Revenue of SMS PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹783 Cr |
| Mar2024 | ₹709 Cr |
| Mar2023 | ₹522 Cr |
| Mar2022 | ₹520 Cr |
| Mar2021 | ₹563 Cr |
How is Revenue of SMS PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹783 Cr | 10.36 | |
| Mar2024 | ₹709 Cr | 35.86 | |
| Mar2023 | ₹522 Cr | 0.42 | |
| Mar2022 | ₹520 Cr | -7.69 | |
| Mar2021 | ₹563 Cr | - | |
Compare Revenue of peers of SMS PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SMS PHARMACEUTICALS | ₹3,563.9 Cr | 0.9% | -0.2% | 49.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,148.0 Cr | 2.6% | 1.2% | 13% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,009.0 Cr | 1.3% | -2.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,779.0 Cr | 1.5% | 0.7% | 37.1% | Stock Analytics | |
| CIPLA | ₹115,772.0 Cr | 6.1% | 2.4% | -5.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,616.0 Cr | 2.6% | -0.4% | -2.1% | Stock Analytics | |
SMS PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SMS PHARMACEUTICALS | 0.9% |
-0.2% |
49.8% |
| SENSEX | -0.8% |
1.4% |
-6.8% |
You may also like the below Video Courses